128 related articles for article (PubMed ID: 1805942)
1. Generation of 5-fluorouracil from 5-fluorocytosine by monoclonal antibody-cytosine deaminase conjugates.
Senter PD; Su PC; Katsuragi T; Sakai T; Cosand WL; Hellström I; Hellström KE
Bioconjug Chem; 1991; 2(6):447-51. PubMed ID: 1805942
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral generation of 5-fluorouracil mediated by an antibody-cytosine deaminase conjugate in combination with 5-fluorocytosine.
Wallace PM; MacMaster JF; Smith VF; Kerr DE; Senter PD; Cosand WL
Cancer Res; 1994 May; 54(10):2719-23. PubMed ID: 8168103
[TBL] [Abstract][Full Text] [Related]
3. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine.
Hirschowitz EA; Ohwada A; Pascal WR; Russi TJ; Crystal RG
Hum Gene Ther; 1995 Aug; 6(8):1055-63. PubMed ID: 7578418
[TBL] [Abstract][Full Text] [Related]
4. Product release is rate-limiting in the activation of the prodrug 5-fluorocytosine by yeast cytosine deaminase.
Yao L; Li Y; Wu Y; Liu A; Yan H
Biochemistry; 2005 Apr; 44(15):5940-7. PubMed ID: 15823054
[TBL] [Abstract][Full Text] [Related]
5. Regional 'pro-drug' gene therapy: intravenous administration of an adenoviral vector expressing the E. coli cytosine deaminase gene and systemic administration of 5-fluorocytosine suppresses growth of hepatic metastasis of colon carcinoma.
Topf N; Worgall S; Hackett NR; Crystal RG
Gene Ther; 1998 Apr; 5(4):507-13. PubMed ID: 9614575
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase.
Huber BE; Austin EA; Richards CA; Davis ST; Good SS
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8302-6. PubMed ID: 8058798
[TBL] [Abstract][Full Text] [Related]
7. Cytosine deaminase as a negative selective marker for Arabidopsis.
Perera RJ; Linard CG; Signer ER
Plant Mol Biol; 1993 Nov; 23(4):793-9. PubMed ID: 8251632
[TBL] [Abstract][Full Text] [Related]
8. Multimodality therapy with a replication-conditional herpes simplex virus 1 mutant that expresses yeast cytosine deaminase for intratumoral conversion of 5-fluorocytosine to 5-fluorouracil.
Nakamura H; Mullen JT; Chandrasekhar S; Pawlik TM; Yoon SS; Tanabe KK
Cancer Res; 2001 Jul; 61(14):5447-52. PubMed ID: 11454690
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral conversion of 5-fluorocytosine to 5-fluorouracil by monoclonal antibody-cytosine deaminase conjugates: noninvasive detection of prodrug activation by magnetic resonance spectroscopy and spectroscopic imaging.
Aboagye EO; Artemov D; Senter PD; Bhujwalla ZM
Cancer Res; 1998 Sep; 58(18):4075-8. PubMed ID: 9751613
[TBL] [Abstract][Full Text] [Related]
10. Cloning, overexpression, and purification of cytosine deaminase from Saccharomyces cerevisiae.
Hayden MS; Linsley PS; Wallace AR; Marquardt H; Kerr DE
Protein Expr Purif; 1998 Mar; 12(2):173-84. PubMed ID: 9518458
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of yeast cytosine deaminase. Insights into enzyme mechanism and evolution.
Ko TP; Lin JJ; Hu CY; Hsu YH; Wang AH; Liaw SH
J Biol Chem; 2003 May; 278(21):19111-7. PubMed ID: 12637534
[TBL] [Abstract][Full Text] [Related]
12. Combined cytosine deaminase expression, 5-fluorocytosine exposure, and radiotherapy increases cytotoxicity to cholangiocarcinoma cells.
Pederson LC; Vickers SM; Buchsbaum DJ; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
J Gastrointest Surg; 1998; 2(3):283-91. PubMed ID: 9841986
[TBL] [Abstract][Full Text] [Related]
13. Role of glutamate 64 in the activation of the prodrug 5-fluorocytosine by yeast cytosine deaminase.
Wang J; Sklenak S; Liu A; Felczak K; Wu Y; Li Y; Yan H
Biochemistry; 2012 Jan; 51(1):475-86. PubMed ID: 22208667
[TBL] [Abstract][Full Text] [Related]
14. Application of monoclonal antibodies against cytosine deaminase for the in vivo clearance of a cytosine deaminase immunoconjugate.
Kerr DE; Garrigues US; Wallace PM; Hellström KE; Hellström I; Senter PD
Bioconjug Chem; 1993; 4(5):353-7. PubMed ID: 8274519
[TBL] [Abstract][Full Text] [Related]
15. Antineoplastic effects in rats of 5-fluorocytosine in combination with cytosine deaminase capsules.
Nishiyama T; Kawamura Y; Kawamoto K; Matsumura H; Yamamoto N; Ito T; Ohyama A; Katsuragi T; Sakai T
Cancer Res; 1985 Apr; 45(4):1753-61. PubMed ID: 3978637
[TBL] [Abstract][Full Text] [Related]
16. Purification and some properties of cytosine deaminase from Salmonella typhimurium.
West TP; Shanley MS; O'Donovan GA
Biochim Biophys Acta; 1982 Nov; 719(2):251-8. PubMed ID: 6758859
[TBL] [Abstract][Full Text] [Related]
17. Genetic construction, expression, and characterization of a single chain anti-CEA antibody fused to cytosine deaminase from yeast.
Zamboni S; Mallano A; Flego M; Ascione A; Dupuis ML; Gellini M; Barca S; Cianfriglia M
Int J Oncol; 2008 Jun; 32(6):1245-51. PubMed ID: 18497986
[TBL] [Abstract][Full Text] [Related]
18. Isocytosine deaminase Vcz as a novel tool for the prodrug cancer therapy.
Kazlauskas A; Darinskas A; Meškys R; Tamašauskas A; Urbonavičius J
BMC Cancer; 2019 Mar; 19(1):197. PubMed ID: 30832616
[TBL] [Abstract][Full Text] [Related]
19. Cytosine deaminase. The roles of divalent metal ions in catalysis.
Porter DJ; Austin EA
J Biol Chem; 1993 Nov; 268(32):24005-11. PubMed ID: 8226944
[TBL] [Abstract][Full Text] [Related]
20. In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase/uracil phosphoribosyltransferase fusion gene.
Erbs P; Regulier E; Kintz J; Leroy P; Poitevin Y; Exinger F; Jund R; Mehtali M
Cancer Res; 2000 Jul; 60(14):3813-22. PubMed ID: 10919655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
